Abstract Details

Title Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications (A Randomized Double-Blind, Placebo-Controlled Study)

Topic Headache and Pain

Presentation(s) (-)

Poster/Presentation
Number 003

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Dileep R. Nair, MD (Cleveland Clinic)	Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroPace. Dr. Nair has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for NeuroPace.
Martha Morrell, MD, FAAN (NeuroPace/Stanford University)	Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has received stock or an ownership interest from NeuroPace.
	No disclosure on file